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Globally, trachoma is the leading infectious cause of
blindness. Survey data consistently show that trachoma-
related blindness is two to four times higher in women than
men. Tracing the increased risk for trachoma and its conse-
quences for women suggests that other factors besides biol-
ogy may contribute. Understanding the reasons for the
excess risk for and consequences of trachoma in girls and
women requires examining a number of issues: Are girls
and women more biologically susceptible to the conse-
quences of infection with Chlamydia trachomatis? Could
other factors help explain the excess of conjunctival scarring
and trichiasis in women? Do gender roles affect the risk for
trachoma and its consequences? Are women more likely to
have recurrence after trichiasis surgery compared to men?
This article explores the answers to these questions.
B
lindness is a major public health concern globally:
approximately 50 million people are blind, and three
times that number are visually impaired. Unless marked
improvements are made in numbers of healthcare person-
nel, infrastructure, and use of services, 75 million cases of
blindness will likely occur by 2020.
Recent evidence has shown that women account for
approximately 64% of global blindness; an age-adjusted
prevalence 39% higher than in men (1). Cataract, the lead-
ing cause of blindness in the world, occurs more common-
ly in women than men (2–3). Paradoxically, in developing
countries the use of cataract surgical services among
women is considerably lower than among men (4). Other
leading causes of blindness include glaucoma, diabetic
retinopathy, and trachoma. 
Trachoma is often referred to as the leading cause of
preventable blindness in the world. It is the leading infec-
tious cause of blindness, followed by diseases such as
onchocerciasis and measles. Systemic diseases such as lep-
rosy and HIV/AIDS also lead to blindness, although much
less frequently.
Trachoma is a chronic infectious eye disease affecting
marginalized population groups throughout many coun-
tries of Africa, the Middle East, Asia, and a few settings in
Latin America. Chlamydia trachomatis, the infective
agent, has no known animal reservoir. The manifestations
of trachoma vary depending upon the number of episodes
of infection, severity, and the persistence of infection.
Trachoma generally occurs early in life through physical
transmission of C. trachomatis to the eye by hands, flies,
or cloth. The pool of chlamydiae in the community gener-
ally resides in preschool-age children (5), and transmission
is easily facilitated by poor hygiene, scarcity of water, and
crowded living conditions. The highest prevalence of
active trachoma in hyperendemic areas is found among
children 1–3 years of age. Adult women are also more like-
ly to have evidence of active disease and infection. 
A single episode of infection will not lead to sequelae;
however, repeated bouts of infection and active disease as
well as persistent infection will lead to scarring of the
upper tarsal conjunctiva. Approximately 10% of children
have persistent infection and many are actively and consis-
tently shedding infectious agent (6). The severity of active
disease will generally dictate the severity of scarring.
Among those with tarsal scarring, a small proportion will
have thickening of the tarsus and deformation of the lid,
whereby the malposition of eyelashes leads to abrasion of
the cornea and, in some cases, corneal ulceration and scar-
ring. Consequently, trachoma occurs throughout patients’
lives, exhibiting different signs and symptoms at different
stages; Figure 1 gives an example of the changes in disease
and its sequelae in trachoma-endemic countries.
Estimates of the number of people affected and blinded
by trachoma have been recently revised; approximately
80–85 million people now have active trachoma, approxi-
mately 8 million have trichiasis, and 3 million are blind.
Most of those affected are found in sub-Saharan Africa, the
Middle East crescent, and parts of Asia. The distribution of
trachoma corresponds with that of poverty in much of
Africa and Asia. Conditions that facilitate the transmission
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University, Baltimore, Maryland, USAof C. trachomatis, such as household crowding and poor
access to and use of water, define risk (7). Because of
changes in disease endemicity, active disease and tra-
chomatous trichiasis are less correlated than they were 50
years ago; for example, active trachoma has disappeared in
most areas of China, where it was once endemic. There
are, however, approximately 2.5 million people in China
blind because of trachoma (8). Trichiasis also remains
common in countries such as Vietnam, where active dis-
ease rates are relatively low. Trachoma has been eliminat-
ed as a public health problem in these settings and others
(such as Tunisia, Saudi Arabia, and Oman) through
improved socioeconomic status, improved environmental
and public health infrastructures (water supply, latrines),
and changed behavior. Nevertheless, because infections
accumulated in the past, trichiasis is likely to develop in
many persons in these countries. 
Productivity losses attributable to trachoma are conser-
vatively estimated at U.S.$2.9 billion annually. This figure
is likely an underestimate of the social cost of the disease
(8).
Trachoma as a Gender-associated Health Issue 
Survey data from virtually every trachoma-endemic
setting have consistently shown that trachoma-related
blindness is two to four times higher in women compared
to men (9–12). Survey data also show that women have an
excess risk for corneal opacity, trichiasis, and scarring;
women account for 60% to 85% of all cases of trichiasis in
the community (11–14). Tracing the excess risk for and
complications of trachoma borne by women through the
course of disease suggests that factors other than biology
are involved. While evidence shows that, by the age of 40,
women are more likely to have severe conjunctival scar-
ring compared to men, the relative effect is not as high as
expected, if a linear association is assumed. The further
back along the course of the disease in a patient, evidence
becomes less and less clear. In young children, the focus of
most active trachoma in a community, the prevalence of
active disease seems to vary, with just a slight excess risk
for girls. In some surveys, such as recently in Dalocha
District in Ethiopia, while 11 of 18 trichiasis cases were in
women, in children <10 years of age, 21.1% of boys and
13.5% of girls had active trachoma (13). However, in
another district in Ethiopia, girls and women were 1.63
times more likely to have active trachoma compared to
boys and men (11). Preschool girls in Tanzania had slight-
ly higher rates of active trachoma than boys; including
adults in the findings showed that female patients had a
twofold excess risk for active trachoma compared to male
patients (14). In most settings, the differences in preva-
lence of active trachoma between girls and boys are not as
striking as they are in women and men (12,15).
Excessive Effect of Trachoma on Women 
Understanding the reasons for the excess risk for and
complications of trachoma in girls and women requires
examining a number of issues. Are females more biologi-
cally susceptible to the consequences of infection with C.
trachomatis? Could other factors (e.g., number of
episodes, persistence of disease, higher bacterial loads)
help explain the excess conjunctival scarring and trichiasis
in women? Do gender roles affect the risk for trachoma
and its consequences? Are women more likely to have
recurrence after trichiasis surgery compared to men?
Biologic Susceptibility to Consequences of
Infection with C. trachomatis
Research in developing countries has not shown that
women or girls are more biologically susceptible to the
consequences of infection with C. trachomatis. However,
research in industrialized countries has demonstrated a
higher prevalence of dry eye syndrome in women, likely
due to hormonal factors. If these findings are applied to
trachoma-endemic settings, they would suggest that
corneal damage is more likely to develop in women with
trichiasis than men. The paucity of longitudinal data ana-
lyzed by sex limits our ability to confirm this hypothesis. 
Other Factors Explaining Excess 
Conjunctival Scarring and Trichiasis in Women 
Recent research in Tanzania suggests that, while girls
have only slightly higher prevalence of active disease than
boys, they account for most of the community load of the
community load of C. trachomatis infection (A. Solomon,
pers. comm.). In a different population in Tanzania, when
the group of children with a heavy bacterial load were
compared to noninfected persons, those with a heavy bac-
terial load were more likely to be younger and to be female
(odds ratio 1.64, 95% confidence intervals 1.1–2.5) and to
live in a house with at least one other person with heavy
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Figure 1. Trachoma as a disease that occurs throughout the life of
a person.infection (16). In a separate study in the same district,
antimicrobial treatment was provided to all residents. At
the 2-month follow-up, the predictors of infection were
being younger and female and having trachomatous
inflammation at baseline assessment before treatment. At 6
months, the strongest predictor of infection was infection
at 2 months; 95% of those with a severe infection at 2
months were infected at 6 months (17). Despite high rates
of antimicrobial coverage in this community, C. trachoma-
tis was reemerging, even among those treated.
These studies suggest that infection loads are higher in
girls and women and that persistent infection is more com-
mon in girls. Longitudinally, this hypothesis is supported
by the 7-year follow-up results on conjunctival scarring.
Of girls with severe active trachoma at the beginning, 33%
eventually had scarring compared to 22% of boys with
similarly severe active trachoma (18). 
Few studies have measured infection with C. trachoma-
tis in adults. In a study of women, infection in adulthood,
although not common, increased the risk for trichiasis 2.5-
fold (19). The few studies with information on infection
show that adult women are more likely than adult men to
be infected (5,20). These data justify treating adults, par-
ticularly women.
In a follow-up study of women in Tanzania, evidence
for persistent infection existed, as several women were
infected at follow-up with the same genovar (21). Whether
men have more or less susceptibility to persistent infection
is not known. 
Effect of Gender Role on Risk Factors for Infection 
Women and girls are the primary caregivers in most
societies in developing countries. Proximity to children
exposes women to repeated infection more than men and is
likely a primary reason for the greater effect of active dis-
ease (22). The close association of mothers with children
makes them more likely to continue to acquire infection
and exposes them to the risk for persistent infection.
Ongoing infection and scarring may explain the almost
four times greater risk compared to men of developing
trichiasis. In central Tanzania, women with preschool-age
children appeared more likely to have active trachoma than
similarly aged women without preschool-age children.
Young girls have the role of childcare in this setting, and
active disease is associated with the status of mother or
caretaker (14). However, a case-control study of trichiasis
in women did not find a significant difference between
childcare activities in those with trichiasis compared to
those without trichiasis; the study design did not permit an
evaluation of infection in the children themselves, which is
the key factor (23). That study did find an increased risk in
women whose mothers also reported trichiasis, which sug-
gests a possible genetic or shared environmental compo-
nent to trichiasis. The absence of rigorous behavioral
research has limited our ability to understand how gender
roles contribute to the progression from infection to clini-
cal disease and its sequelae.
In many Islamic countries the use of kohl and other tra-
ditional products for preventing eye diseases, treating eye
diseases, and “brightening” the eyes is common and can be
implicated in disease transmission within the household
and community (24). In addition, some of these traditional
products are applied by everting the lid, moistening the
product with saliva, and rubbing the compound directly
onto the tarsus. This procedure may further scar the tarsus
and spread bacteria from the nasopharynx. These products
are used among both young boys and girls, but continued
use in adulthood is limited primarily to women. This prac-
tice may be another way in which gender roles contribute
to the excessive effects of trachoma in women.
Recurrence after Trichiasis Surgery
Recurrence after surgery to correct trichiasis is not
uncommon. Recurrence rates reflect both poor quality of
surgery (recurrence usually occurring within 6 months of
surgery) or other pathologic processes (e.g., continued
contracture of the tarsal conjunctiva, reinfection).
Recurrence, measured cross-sectionally, may reflect both
of these conditions; measured prospectively, determining
the apparent contribution of each factor is easier. Most
studies of the outcome of trichiasis surgery had few
patients enrolled and lacked adequate power to compare
differences between men and women (25). Omani women
and men, with 3- to 5-year follow-up data, had unequal
rates of recurrence. Overall, 61.3% of surgeries in women
were associated with recurrences compared to 48.9%
among men (26). West et al., in their large series of cases
in Tanzania, found no difference by sex in recurrence rates
up to 8 years (E. West, pers. comm.). Cross-sectional stud-
ies indicate that women are more likely to have recurrence
compared to men. In the recent Egyptian study, trichiasis
recurred after surgery in 44.4% of women compared to
37.7% of men (10).
Possible reasons for the differences are multiple and
may overlap: Women may have had more severe trichiasis
before surgery, which is a known risk factor for recurrence
(27). In some settings, women use surgical services less or
may wait until trichiasis is more advanced before surgery.
Finally, reinfection may play a role in recurrence. As
noted, infection in adulthood increases the risk for trichia-
sis 2.5-fold (19). In the Omani study (26), recurrence was
approximately three times higher in persons with infective
conjunctivitis compared to those without conjunctivitis.
All these potential explanations point to gender role–medi-
ated factors more than sex-linked factors. Gender roles in
most societies in trachoma-endemic countries account for
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infection seen in men and women (Figure 2). 
Public Health Approaches to Trachoma 
Control and Gender Equity
Eliminating trachoma as a blinding disease is the goal
of the Alliance for the Global Elimination of Trachoma by
2020. The Alliance has adopted a four-part strategy,
referred to as the SAFE strategy, which includes surgery to
correct trichiasis, antimicrobial agents to treat active tra-
choma, and face washing and environmental changes to
prevent transmission. Adopting the SAFE strategy, while
not explicitly gender-sensitive, would necessitate consid-
ering gender in implementation. 
Few national trachoma control programs monitor use of
trichiasis surgery separately for men and women. Fewer
still have adequate information on the proportion of trichi-
asis patients who have had surgery. This lack of this infor-
mation limits evaluation of program progress, gender
based or not. Data from the Tanzania and Vietnam pro-
grams suggest that these countries have gender equity in
trichiasis surgery (28). However, programs directed at
increasing the number of persons receiving surgery to cor-
rect trichiasis have generally not been explicitly gender-
sensitive, and publications on uptake of services have
rarely compared men and women. Gender equity in use
thus remains unknown in most settings.
Similarly, trachoma control programs have tended to
measure antimicrobial coverage as a single, community-
wide or districtwide measure, without assessing rates of
compliance by age and sex. Research on compliance from
Rombo district in Tanzania showed that compliance with
azithromycin treatment was higher among women (80.2%)
than men (73.3%). However, as pregnant women are not
eligible to receive azithromycin and must use topical tetra-
cycline, interpreting coverage findings is not straightfor-
ward (29). The authors suggested that, since childcare is
primarily the concern of women, they were more likely to
attend the distribution of azithromycin by bringing their
children and thus are more likely than men to receive drugs
for themselves. Furthermore, the authors suggested that
patient or recipient expectations contributed to compliance
and that the expectations of women were influenced to a
greater extent than those of men by their children’s illness
(N. Desmond, pers. comm.). Current recommendations
promote a minimum antimicrobial coverage (whole popu-
lation) of 80%; evaluation is needed to assess if women are
more or less likely to get an antimicrobial agent.
Although the antimicrobial agent is currently donated
free-of-charge, the cost of distribution remains high
(approximately U.S$0.50 per dose) (30). This cost is borne
by various governmental and nongovernmental agencies;
however, how long this can continue is not clear.
Willingness to pay for research in Tanzania has demon-
strated that those at higher risk for trachoma were less will-
ing to pay for future treatment. This group included
female-headed households (31). Only higher maternal edu-
cation was associated with willingness to pay. 
Approaches to preventing trachoma in the SAFE strat-
egy, namely, face washing and environmental changes,
have not been researched to the same extent that surgery
and antimicrobial use have. Research in the early 1990s
demonstrated the effectiveness of face washing in tra-
choma reduction (32). Cross-sectional studies of risk fac-
tors have consistently showed a strong association
between the presence of active trachoma and the absence
of good sanitary conditions (primarily the absence of
latrines and the high concentration of flies). Assessment of
environmental conditions (including water supply) is
household- or community-based, rather than individually
based, thus limiting the ability to evaluate gender-specific
characteristics. Nevertheless, the fact that women and girls
are primarily responsible for water collection, face wash-
ing, and cleaning (if done) of latrines suggests that intro-
ducing improved infrastructures will have the greatest
effect on women, both in terms of eliminating trachoma
and improving quality of life. Women’s and girls’ roles
also suggest that most hygiene and environmental compo-
nents of trachoma control will fall to women as well. Thus,
for example, in the absence of water in the villages, con-
vincing women to use scarce water that they must collect
for washing purposes is difficult. 
Trachoma remains a major problem, particularly
among girls and women, in much of sub-Saharan Africa,
areas of the Middle East crescent, and pockets of Asia and
South America. Eliminating trachoma, while possible, will
require a rededication to prevention strategies and a focus
on disease control as a gender-sensitive intervention. 
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Figure 2. Contribution of gender and sex-linked biology to the pro-
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